← Eichor
Condition: Renal Anemia Of Chronic Kidney Disease Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Renal Anemia Of Chronic Kidney Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney D
Phase 3 · 1 location(s) · Kind Pharmaceuticals LLC · NCT07487727Pegmolesatide Treatment for Anemia in Patients Undergoing Long-term Dialysis
Phase 4 · 1 location(s) · Chinese PLA General Hospital · NCT07045155Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis Patients
Phase 1/Phase 2 · 1 location(s) · Mansoura University · NCT06903559The Effect of Salicylate on Platelet Function in CKD (Chronic Kidney Disease) Patients Treated With Aranesp
NA · 1 location(s) · Zealand University Hospital · NCT04330729Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa
Phase N/A · 1 location(s) · Swiss Tropical & Public Health Institute · NCT05881447A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatmen
Phase 3 · 21 location(s) · AMAG Pharmaceuticals, Inc. · NCT03619850A Study of Pegmolesatide of in Dialysis Chronic Kidney Disease (CKD) Patients With Anemia Treated With Hypoxia-inducible
NA · 24 location(s) · Guangdong Provincial People's Hospital · NCT07136792A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With An
Phase 3 · 1 location(s) · Kind Pharmaceuticals LLC · NCT07494409Oral Iron in Children With Chronic Kidney Disease
Phase 4 · 2 location(s) · Weill Medical College of Cornell University · NCT03991169Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Dise
Phase 3 · 2 location(s) · Biocad · NCT07119372FGF23 and Cardiovascular Damage in Anemia With an Without Chronic Kidney Disease.
Phase N/A · 1 location(s) · Maimónides Biomedical Research Institute of Córdoba · NCT05356325Impact of Dapagliflozin in Anemic Chronic Kidney Disease Patients
Phase 2 · 1 location(s) · Mansoura University · NCT06897605Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168Integrated Diagnosis and Treatment of CKD on Outcomes
Phase N/A · 1 location(s) · Capital Medical University · NCT05242055The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.
Phase N/A · 38 location(s) · Russian Federation of Anesthesiologists and Reanimatologists · NCT03945968A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
Phase 3 · 58 location(s) · Genexine, Inc. · NCT06466785Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease
Phase 4 · 1 location(s) · Shanghai Zhongshan Hospital · NCT06725810A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic
Phase 4 · 1 location(s) · Zydus Lifesciences Limited · NCT05515367A Study of Luspatercept in People With Anemia
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07725497Roxadustat for Bone and Neuropsychiatric Aspects in Hemodialysis Patients
Phase 1/Phase 2 · 1 location(s) · Mansoura University · NCT06917950A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Phase 3 · 47 location(s) · Astellas Pharma Global Development, Inc. · NCT05970172Studies on Adsorption International Learning Initiative Global
NA · 1 location(s) · Botkin Hospital · NCT07123909Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT01087333A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults.
EARLY_Phase 1 · 1 location(s) · Cajal Therapeutics Inc. · NCT07577817
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.